CMP : 28


Medicamen Biotech Ltd. manufactures and markets pharmaceutical formulations in the overseas and domestic markets. The Company's products include AntiRetroviral, Anti-Malarial, Antibiotics and Anti TB Drugs.

Medicamen Biotech is a 21 Cr penny cap pharma stock. Its pretty high and consistent on revenues and a little low on NPM at 4%. Its consistent revenues make it a safer pick. NPM leaves room for improvement and current P/E of less than 6 makes it a good bet.